Home
/
Investor Relations
/
Event Details
Overview Press Releases Events & Presentations Financials & SEC Filings Stock Information Analyst Coverage Corporate Governance Investor FAQs Email Alerts
Investor Contacts
ir@allovir.com
Media Contacts
AlloVirPR@scientpr.com

Event Details

AlloVir Virtual Investor Event with KOLs on Multi-Virus Prevention

Dec 14, 2022 at 4:30 PM EST

In this webcast presentation AlloVir's CEO, Diana Brainard, meets with infectious disease specialist Sanjeet Singh Dadwal, M.D., City of Hope and hematologist-oncologist and transplant specialist Joseph McGuirk, D.O., University of Kansas Medical Center to discuss the unmet medical need for and clinical value of a multi-virus prevention approach in the management of allo-HCT patients.

You are now leaving AlloVir’s website.

AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
yes no

You are now leaving AlloVir’s website.

AlloVir does not control and is not responsible for the content on the website you are about to visit. AlloVir is providing this link as a convenience, and this link does not imply AlloVir’s endorsement of any material on the website you are about to visit. Do you wish to continue?
yes no